Description: As companies have reported their latest financials for 2023, LDTI is in its full swing for the public companies. Under US GAAP reinsurance accounting methods can be daunting. Add onto this legacy practices related to reinsurance reporting and this may lead to significant unwinding and implementation efforts. This session will discuss industry practices commonly applied to US GAAP reinsurance reported balances such that LDTI adopters can gather deeper insights into the LDTI impact. Specifically, the session will explain the two most popular methods to value reinsurance under LDTI, methods applying a direct measurement of the reinsurance net cost and a method that recognizes ceded asset balances and a cost of reinsurance (“CoRe”). The session will present simplified direct and ceded models to demonstrate how the actuarial balances under LDTI impact GAAP book profits for different underlying products and reinsurance types.

Description: Gather with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, pension, investment, product strategy, and more.

Description: IFRS 17 will be effective as of 1 Jan 2023 and provide opportunities as well as challenges to both Direct Writers and Reinsurers across the insurance industry. If the new framework is not fully understood, an implementation can elevate the risk of problems in financial reporting, product development, investment management and more. The transition to IFRS provides an opportunity for companies to optimize the financial position of the enterprise by implementing mitigating strategies to reduce the risks and challenges that IFRS brings to the table.

Description: This session will address the risk management, reserving and capital issues associated with index-linked annuities including financial reporting considerations for FIAs and RILAs, benefits of combining VA and RILA hedging and reserving under VM-21, current and future challenges with FIA reserving under VM-22, potential capital redundancy for FIAs, RILA interim values under AG 54, NAIC economic scenario reform, asset modeling, fund mapping and more!

Description: This session series is sponsored by Hannover Re Session 2 - COVID-19: Financial Impacts and Re-shaping Risk and Capital Management Practices COVID-19 has posed significant challenges to health insurers and providers to meet profit targets and maintain strong balance sheets and capitalization levels. As a result, companies are facing an ever-increasing need to better integrate their risk and capital management practices across the enterprise and evaluate a broader set of tools to manage and optimize their capital and liquidity needs. This second session of the COVID-19 series will help you examine the financial impact that COVID-19 has had on the health industry and review how companies are evolving their financial and capital management practices to achieve their strategic goals. It will also outline how structured reinsurance has emerged as an increasingly utilized form of managing capital. By attending this session, you will be able to explain how COVID-19 has impacted the financial performance and capitalization of the health insurance industry, and will gain a basic understanding of alternative ways of managing and optimizing capital, including the use of structired reinsurance.

Description: This session will provide an update on regulatory changes and current hot topics in Bermuda. The speakers will update you on the most recent Bermuda regulatory reforms, including targeted enhancements to its regulatory capital framework, Own Risk and Insolvency Amendment (ORSA)/Commercial Insurer's Insolvency Self Assessment (CISSA) enhancements for climate risk assessment, and Bermuda corporate income tax changes to align with Global Minimum Tax.

Description: Join us for this popular annual webcast covering the latest considerations for the year's U.S. statutory financial reporting work. Get ready to hear from three expert speakers, who will discuss cash flow testing and this year’s New York and California holiday letters, the impact of recent interest rate changes including treatment of negative IMR, potential changes to statutory financial reporting due to climate change, and updates regarding Principle Based Reserves.